Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Ovarian Cancer Recurrent × EP-100 membrane-disrupting peptide × 90 days × Clear all

Sponsor

Interventions

poly(I).poly(c12,U) 1 pembrolizumab 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡